Cart
sales@molnova.com
Creatine phosphate disodium salt tetrahydrate
CAS No. 71519-72-7
Creatine phosphate disodium salt tetrahydrate( Sodium creatine phosphate dibasic tetrahydrate )
Catalog No. M19700 CAS No. 71519-72-7
Creatine phosphate disodium salt tetrahydrate is a substrate for the assay of creatine kinase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 45 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCreatine phosphate disodium salt tetrahydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCreatine phosphate disodium salt tetrahydrate is a substrate for the assay of creatine kinase.
-
DescriptionCreatine phosphate disodium salt tetrahydrate is a substrate for the assay of creatine kinase.
-
In Vitro——
-
In Vivo——
-
SynonymsSodium creatine phosphate dibasic tetrahydrate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number71519-72-7
-
Formula Weight345.15
-
Molecular FormulaC4H18N3Na2O10P
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILES[Na+].[Na+].O.O.O.O.N=C(NP([O-])(=O)O)N(C)CC([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kucherenko IS et al. Determination of total creatine kinase activity in blood serum using an amperometric biosensor based on glucose oxidase and hexokinase. Talanta. 2015 Nov 1;144:604-11.
molnova catalog
related products
-
7-keto-deoxycholic a...
7-keto-deoxycholic acid is converted from Lactobacillus and Bifidobacterium with specific condition and from cholic acid in vitro.
-
1-Methoxyphaseollidi...
1-Methoxyphaseollidin exhibits anti-Helicobacter pylori activity against the CLAR and AMOX-resistant strain as well as four CLAR (AMOX)-sensitive strains.
-
Norcholic Acid
Norcholic Acid (Nor Cholic Acid) is a bile acid that promotes tumor progression and immune escape by modulating the farnesol X receptor in hepatocellular carcinoma.
